Bolt Biotherapeutics (BOLT) Total Non-Current Liabilities (2020 - 2026)
Bolt Biotherapeutics' Total Non-Current Liabilities came in at $27.57 million for Q2 2026, down 24.5% from $36.52 million a year earlier and down 1.7% from the prior quarter.
Powered by 
Analysis
Bolt Biotherapeutics (BOLT) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
At the end of FY2025, Bolt Biotherapeutics' Total Non-Current Liabilities was $30.11 million, down 29.0% from FY2024.
- Total Non-Current Liabilities has declined in each of the last five years, with a five-year compound annual growth rate of -27.6% (FY2020 to FY2025).
- Going back by year, Total Non-Current Liabilities was $42.43 million in FY2024 (-9.7%), $47 million in FY2023 (-16.5%), $56.26 million in FY2022 (-2.0%) and $57.39 million in FY2021 (-62.0%).
- The Q2 2026 figure represents the lowest quarterly Total Non-Current Liabilities since Q1 2021.
- Year-over-year, Total Non-Current Liabilities has declined for five consecutive quarters, with an average decline of 16.0% over the last eight quarters.
- The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q1 2022 (growth of 157.2%), and the weakest in Q4 2021 (a decline of 62.0%).
- Business Quant data shows BOLT's Total Non-Current Liabilities at $28.05 million (Q1 2026), $30.11 million (Q4 2025) and $32.82 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.70 Bn | 1,135.28 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 633.99 Bn | 552.52 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 502.96 Bn | 476.07 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 377.09 Bn | 331.47 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 303.78 Bn | 267.77 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 266.66 Bn | 240.35 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 241.39 Bn | 196.79 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 172.37 Bn | 119.01 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Bolt Biotherapeutics | 8.04 Mn | -10.06 Mn | - | 27.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.57 Mn |
| Mar 31, 2026 | 28.05 Mn |
| Dec 31, 2025 | 30.11 Mn |
| Sep 30, 2025 | 32.82 Mn |
| Jun 30, 2025 | 36.52 Mn |
| Mar 31, 2025 | 38.92 Mn |
| Dec 31, 2024 | 42.43 Mn |
| Sep 30, 2024 | 37.30 Mn |
| Jun 30, 2024 | 38.32 Mn |
| Mar 31, 2024 | 38.73 Mn |
| Dec 31, 2023 | 47.00 Mn |
| Sep 30, 2023 | 47.05 Mn |
| Jun 30, 2023 | 48.52 Mn |
| Mar 31, 2023 | 48.45 Mn |
| Dec 31, 2022 | 56.26 Mn |
| Sep 30, 2022 | 56.86 Mn |
| Jun 30, 2022 | 52.07 Mn |
| Mar 31, 2022 | 54.20 Mn |
| Dec 31, 2021 | 57.39 Mn |
| Sep 30, 2021 | 58.42 Mn |
API Access
Bolt Biotherapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BOLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "BOLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BOLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();